Hormonal treatment aims mostly at improving levels of endogenous follicle stirring hormone and/or androgen and subsequent spermatogenesis. Treatment with gonadotrophins such as Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) may be active in patients with hypogonadotrophic hypogonadism. As an example, Tamoxifen citrate is an anti-estrogenic agent, used as a single prophylactic agent in hormone responsive breast cancer. This drug is to recover sperm quality in patients with asthenozoospermia.
Peer review refers to the work done during the screening of submitted manuscripts and funding applications. This process encourages authors to meet the accepted standards of their discipline and reduces the dissemination of irrelevant findings, unwarranted claims, unacceptable interpretations, and personal views. Publications that have not undergone peer review are likely to be regarded with suspicion by academic scholars and professionals.
Last date updated on March, 2021